Estados Unidos · Plataformas y datos · MarketBeat

Milestone Pharmaceuticals (NASDAQ:MIST) Stock Rating Upgraded by Wall Street Zen

Publicado por MarketBeat · Estados Unidos hace 14 min

Image from MarketBeat Media, LLC. · MarketBeat

Resumen detallado

Wall Street Zen raised shares of Milestone Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday.

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

También te puede interesar

The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than SpaceX 5 Years From Now

ArrowMark Financial declares $0.15 dividend

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Trump Reportedly Plans To Not Raise Nvidia Spy Issue During China Trip — Elon Musk To Accompany US President

Planning to Claim Social Security at 62? Here Are 3 Critical Questions to Ask Yourself First

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker